Back to top

Image: Bigstock

Johnson & Johnson (JNJ) Catches Eye: Stock Jumps 7.4%

Read MoreHide Full Article

Johnson & Johnson (JNJ - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $125.41 –$149.93 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Johnson & Johnson currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Johnson & Johnson Price

Investors interested in the Large Cap Pharmaceuticals industry may consider AbbVie Inc. (ABBV - Free Report) , which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Johnson & Johnson (JNJ) - free report >>

AbbVie Inc. (ABBV) - free report >>